Two New Vaccines Join COVID Fight As China Ships Millions Overseas
Newcomers to Speed Up Slow Domestic Rollout?
CanSino's adenovirus-based COVID-19 vaccine, along with another from state-owned Sinopharm, have been granted prompt conditional approvals in China, taking to four the number approved in the country and as Beijing ships millions of doses around the world.
